Chiyoda-ku, Japan

Iwao Chujo



 

Average Co-Inventor Count = 4.6

ph-index = 1


Location History:

  • Kaizuka, JP (2010)
  • Chiyoda-ku, JP (2019 - 2021)

Company Filing History:


Years Active: 2010-2021

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Iwao Chujo: Innovator in Thiazole Derivative Production

Introduction

Iwao Chujo is a notable inventor based in Chiyoda-ku, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the production of thiazole derivatives. With a total of 4 patents, his work has implications for various therapeutic applications.

Latest Patents

Chujo's latest patents focus on a production method of thiazole derivatives, which are represented by a specific formula. These compounds exhibit adenosine A receptor antagonistic action, making them useful as therapeutic agents for conditions such as Parkinson's disease, sleep disorders, analgesic resistance to opioids, migraines, movement disorders, depression, and anxiety disorders. The production method involves a reaction between compounds represented by specific formulas, highlighting the complexity and innovation in his approach.

Career Highlights

Throughout his career, Iwao Chujo has worked with prominent companies in the pharmaceutical industry, including Kyowa Kirin Co., Ltd. and Kyowa Hakko Kirin Co., Limited. His experience in these organizations has allowed him to develop and refine his innovative methods in drug production.

Collaborations

Chujo has collaborated with esteemed colleagues such as Takamasa Sugita and Arata Yanagisawa. These partnerships have likely contributed to the advancement of his research and the successful development of his patented methods.

Conclusion

Iwao Chujo's contributions to the field of medicinal chemistry, particularly through his innovative production methods for thiazole derivatives, demonstrate his commitment to advancing therapeutic solutions. His work continues to impact the medical community positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…